Gossamer Bio, Inc. (GOSS)
2.54
-0.12
(-4.51%)
USD |
NASDAQ |
Jan 14, 16:00
2.54
0.00 (0.00%)
After-Hours: 19:26
Gossamer Bio Research and Development Expense (Annual): 137.65M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 235.62M |
| XOMA Royalty Corp. | 2.875M |
| Rezolute, Inc. | 61.53M |
| Axsome Therapeutics, Inc. | 186.54M |
| Crinetics Pharmaceuticals, Inc. | 237.37M |